📰 Leukemia News
Page 92 - Leukemia News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Leukemia. Real-time updates on events, politics, business and more.
November 9, 2023
The FDA has granted priority review to the supplemental biologics license application seeking approval to expand the indication of lisocabtagene maraleucel to include patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who had prior exposure to a BTK inhibitor and a BCL-2 inhibitor.
November 8, 2023
The associations between body mass index (BMI) among young males and new-onset site-specific tumors.
November 8, 2023
Researchers have identified biomarkers, alongside clinical risk factors, that may provide better cancer risk assessment and identify individuals who should be screened.
November 7, 2023
A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), may offer a new treatment option for patients with blood cancers, including chronic lymphocytic leukemia (CLL) and Non-Hodgkin lymphoma (NHL) whose disease has stopped responding to standard treatments.
November 7, 2023
Unlike previous research, a recent study examines exposure to fine particulate matter pollution at home and at the workplace.
November 7, 2023
An expert provided an overview of the promising therapies that are being investigated for the treatment of patients with chronic lymphocytic leukemia.
November 7, 2023
A new analysis suggests that the treatments benefits for overall survival endures for at least 36 months.
November 3, 2023
A study evaluating disparities among children with acute leukemia found that Black children are more likely to present with higher disease burden at diagnosis compared with non-Hispanic White children.
November 3, 2023
CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it...